Ammar Al-Chalabi's research focuses on amyotrophic lateral sclerosis, also known as ALS or motor neuron disease. His research team works on finding the causes of ALS, and what might influence the way the disease manifests and progresses, particularly where this involves genes, environmental exposures, or changes in thinking and coping. He leads the Motor Neuron Disease reseach theme at the NIHR Maudsley Biomedical Research Centre.

Prof Al-Chalabi's has also held fellowships and exchange positions abroad at Massachusetts General Hospital, Harvard University and Cold Spring Harbor Laboratory. He set up the MSc in Clinical Neuroscience at King's College London, which is our clinical research trainee programme.

He has authored more than 250 peer-reviewed papers and hold extensive external grant funding, including three current and six recently completed programme grants, as well as funding from Medical Research Council, Horizon 2020, and National Institute for Health and Care Research.